Genpharmasec Ltd

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Genpharmasec Limited, a micro-cap trading and distribution company with a market capitalisation of ₹64.00 crores, has reported deeply concerning results for Q3 FY26 (October-December 2025), posting a net loss of ₹0.83 crores despite achieving its highest-ever quarterly revenue. The stock, currently trading at ₹1.16, has plummeted 48.21% over the past year and trades 51.67% below its 52-week high of ₹2.40, reflecting mounting investor concerns about the company's profitability trajectory.

Genpharmasec Ltd, a company operating in the Trading & Distributors sector, has reached a new 52-week low of Rs.0.98, marking a significant decline in its stock price. This fresh low reflects ongoing pressures on the stock, which has underperformed both its sector and the broader market over the past year.

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Genpharmasec Ltd’s share price declined to a fresh 52-week low of Rs.1.06 today, marking a significant milestone in its ongoing downward trajectory. This new low reflects persistent pressures on the stock amid broader market weakness and company-specific factors.

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Genpharmasec Ltd’s shares declined to a fresh 52-week and all-time low of Rs.1.23 on 12 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its valuation and financial metrics.

Genpharmasec Ltd’s shares declined to a fresh 52-week low of Rs.1.24 on 9 Jan 2026, marking a significant drop amid persistent underperformance relative to its sector and benchmark indices.

Genpharmasec Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 07 January 2026, providing investors with the latest comprehensive view of the company’s position.

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Genpharmasec has reached a new 52-week low of Rs.1.29, marking a significant decline in its share price amid a persistent downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing challenges in its financial performance and market positioning.

Genpharmasec's stock price reached a new 52-week low of Rs.1.3 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock's current trading levels reflect ongoing challenges within the Trading & Distributors sector, contrasting with the relatively stable performance of benchmark indices.

Genpharmasec, a company operating in the Trading & Distributors sector, has reached a new 52-week low of Rs.1.34 today, marking a significant decline in its stock price amid broader market dynamics and company-specific factors.

Genpharmasec, a microcap player in the Trading & Distributors sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a period marked by notable stock price declines and mixed fundamental indicators.

Genpharmasec has reached a new 52-week low, closing at Rs.1.37, marking a significant decline amid persistent downward momentum over recent sessions. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Trading & Distributors sector.